Pharmacokinetics of RLS-0071, a Novel Anti-Inflammatory Peptide, in Newborns...
Background: Hypoxic ischemic encephalopathy (HIE) is a common cause of mortality and life-long disabilities. RLS-0071 is a novel anti-inflammatory peptide...
Read MoreEarly Granulocyte Inflammatory Biomarkers in Newborn Babies with Moderate...
Background: Hypoxic ischemic encephalopathy (HIE) occurs when an infant’s brain is deprived of oxygenated blood flow during the perinatal period....
Read MoreExploring a Novel Anti-Inflammatory Peptide As a Potential Treatment...
Introduction: Allogeneic hematopoietic cell transplantation (allo-HCT) is indicated for the treatment of many hematological diseases, including leukemia. The goal is...
Read MoreRLS-0071, A Novel Dual-targeting Anti-inflammatory Agent, Demonstrates Proof of...
RATIONALE: Neutrophils play an important role in several lung diseases such as acute lung injury, adult respiratory distress syndrome (ARDS),...
Read MoreThe EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides,...
Abstract The EPICC peptides are a family of peptides that have been developed from the sequence of the capsid protein...
Read MorePeptide inhibition of acute lung injury in a novel...
Acute lung injury (ALI) often causes severe trauma that may progress to significant morbidity and mortality. ALI results from a...
Read MoreClassical complement pathway inhibition reduces brain damage in a...
Abstract Perinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played...
Read MoreDelayed Hemolytic Transfusion Reaction in a Patient With Sickle...
A 14-year-old female patient with sickle cell disease developed a severe delayed hemolytic transfusion reaction (DHTR) leading to multiple transfusions...
Read MoreA complement-mediated rat xenotransfusion model of platelet refractoriness
Background: Platelet refractoriness remains a challenging clinical dilemma although significant advancements have been made in identifying human leukocyte antigen (HLA)...
Read More